Amgen

Amgen Challenges Novo Nordisk's Ozempic And Eli Lilly's Zepbound As Its Monthly Weight Loss Drug MariTide Enters Two Late-Stage Trials
Amgen Challenges Novo Nordisk's Ozempic And Eli Lilly's Zepbound As Its Monthly Weight Loss Drug MariTide Enters Two Late-Stage Trials
FTC Takes A Rare Step Back, Pauses Legal Battle With Amgen Over $28B Horizon Deal
FTC Takes A Rare Step Back, Pauses Legal Battle With Amgen Over $28B Horizon Deal
The Latest Picks And Pans From Barron's: Barrick Gold, BioNTech, Facebook, WW And More
The Latest Picks And Pans From Barron's: Barrick Gold, BioNTech, Facebook, WW And More
FTC Takes A Rare Step Back, Pauses Legal Battle With Amgen Over $28B Horizon Deal
FTC Takes A Rare Step Back, Pauses Legal Battle With Amgen Over $28B Horizon Deal
The Latest Picks And Pans From Barron's: Barrick Gold, BioNTech, Facebook, WW And More
The Latest Picks And Pans From Barron's: Barrick Gold, BioNTech, Facebook, WW And More
Barron's Latest Picks And Pans: Apple, Coupang, GameStop, Uber, Walker & Dunlop And More
Barron's Latest Picks And Pans: Apple, Coupang, GameStop, Uber, Walker & Dunlop And More
Benzinga's Bulls & Bears Of The Week: Altria, DowDupont, Oracle, Roku And More
Benzinga's Bulls & Bears Of The Week: Altria, DowDupont, Oracle, Roku And More
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved